News
VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q4 2025 Earnings Call Transcript June 17, 2025 VistaGen Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.43, expectations were $-0.52.
The bill the House GOP just passed is calling for trillions in tax cuts that heavily benefit billionaires—“paid for” with devastating cuts in education, health, ... Urge your Senators to reject these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback